Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/27/25 19:19 | 11/17/23 | KLRS | Health | BioPrd | Biological Products, (No Diag | Hagen Brett R | CA | O | Chief Ac | 23 | S.m | -52 | 0.8719 | 0 | -59 | 126 | D | |||||||||||||||
2/24/25 16:15 | 11/17/23 | ALVR | Health | BioPrd | Biological Products, (No Diag | Sinha Vikas | MA | DOT | See Rema | 20 | S.m | -54 | 0.8110 | 0 | -67 | 0 | 17,843 | D | ||||||||||||||
2/24/25 16:15 | 2/21/25 | ALVR | Health | BioPrd | Biological Products, (No Diag | Miller Edward | MA | O | GC | 19 | S.m | -20 | 0.7792 | 0 | -25 | 524 | D | |||||||||||||||
11/20/24 16:15 | 11/17/23 | ALVR | Health | BioPrd | Biological Products, (No Diag | Brainard Diana | MA | DO | CEO | 19 | S.m | -121 | 0.7638 | 0 | -159 | 875 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |